Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Stockholders' Deficit

v3.19.3.a.u2
Consolidated Statements of Stockholders' Deficit - USD ($)
Total
Common Stock [Member]
Additional Paid-In Capital [Member]
Treasury Stock [Member]
Other Comprehensive Income [Member]
Accumulated Deficit [Member]
Beginning balance at Nov. 30, 2017 $ (12,502,896) $ 128,995 $ 31,373,048 $ (19,571,113) $ 40,865 $ (24,474,691)
Beginning balance, shares at Nov. 30, 2017   12,899,517        
Common stock issued 3,670,925 $ 6,969 3,663,956      
Common stock issued, shares   696,892        
Compensatory element of stock options 478,378   478,378      
Unrealized loss on available for sale securities 300,119       300,119  
Net income (loss) (854,824)         (854,824)
Ending balance at Nov. 30, 2018 (8,908,298) $ 135,964 35,515,382 (19,571,113) 340,984 (25,329,515)
Ending balance, shares at Nov. 30, 2018   13,596,409        
Common stock issued 5,700 $ 25 5,675      
Common stock issued, shares   2,500        
Compensatory element of stock options 397,770   397,770      
Cumulative-effect adjustment due to the adoption of ASU 2016-01 | Accounting Standards Update 2016-01 [Member]         $ (340,984) 340,984
Unrealized loss on available for sale securities 0          
ASC 606 adoption adjustment, net of tax 253,447         253,447
Treasury Stock (992,244)     (992,244)    
Net income (loss) 2,290,774         2,290,774
Ending balance at Nov. 30, 2019 $ (6,952,851) $ 135,989 $ 35,918,827 $ (20,563,357)   $ (22,444,310)
Ending balance, shares at Nov. 30, 2019   13,598,909